These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16494584)

  • 1. Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Am J Gastroenterol; 2006 Apr; 101(4):842-7. PubMed ID: 16494584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin monotherapy for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005527. PubMed ID: 19821346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD011132. PubMed ID: 24937404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin with or without alpha interferon for chronic hepatitis C.
    Kjaergard LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2002; (2):CD002234. PubMed ID: 12076442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin monotherapy for chronic hepatitis C.
    Brok J; Gluud L; Gluud C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005527. PubMed ID: 16235408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.
    Gluud LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2007 Jul; 2002(2):CD002234. PubMed ID: 17636700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.
    Kjaergard LL; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2002; (1):CD002234. PubMed ID: 11869633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin plus interferon versus interferon for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2005 Jul; (3):CD005445. PubMed ID: 16034976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin plus interferon versus interferon for chronic hepatitis C.
    Brok J; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005445. PubMed ID: 20091577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.
    Cummings KJ; Lee SM; West ES; Cid-Ruzafa J; Fein SG; Aoki Y; Sulkowski MS; Goodman SN
    JAMA; 2001 Jan; 285(2):193-9. PubMed ID: 11176813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: ribavirin plus interferon vs. interferon monotherapy for chronic hepatitic C - an updated Cochrane review.
    Brok J; Gluud LL; Gluud C
    Aliment Pharmacol Ther; 2010 Oct; 32(7):840-50. PubMed ID: 20839385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review.
    Shepherd J; Waugh N; Hewitson P
    Health Technol Assess; 2000; 4(33):1-67. PubMed ID: 11134916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
    Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
    Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.
    Scott LJ; Perry CM
    Drugs; 2002; 62(3):507-56. PubMed ID: 11827565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.
    Simin M; Brok J; Stimac D; Gluud C; Gluud LL
    Aliment Pharmacol Ther; 2007 May; 25(10):1153-62. PubMed ID: 17451561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis.
    Kim AI; Dorn A; Bouajram R; Saab S
    HIV Med; 2007 Jul; 8(5):312-21. PubMed ID: 17561878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.
    Shiffman ML; Hofmann CM; Gabbay J; Luketic VA; Sterling RK; Sanyal AJ; Contos MJ; Ryan MJ; Yoshida C; Rustgi V
    Am J Gastroenterol; 2000 Oct; 95(10):2928-35. PubMed ID: 11051370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.